This confirms IGF2BP1 as a conserved ‘oncogenic’ m6A-reader in cancer and supports the view that IGF2BP1 impairs the miRNA-directed decay of target mRNAs by sequestering transcripts in miRNA-/RISC-free mRNPs (6,9). The gene discussed is IGF2BP1; the disease is cancer.